Dr. Tourigny’s drug cocktails, which include drugs similar to protease inhibitors used to treat HIV infection, are intended to help stop progression of the disease and other positive outcomes, including preventing cirrhosis, reducing risk for liver cancer and reducing the need for liver transplantation.
Such drug therapies are available to patients at CarolinaEast Gastroenterology, and their use has brought about positive results, according to the report.
Related Articles on Gastroenterologists:
West Side GI Surgery Center Opens in Manhattan
Gastroenterologist Dr. Max Schneider Retires at 90
Gastroenterologist Dr. Imad Idriss Recognized by NM’s Memorial Medical Center
